Genome-wide CRISPR/Cas9 screen identifies AraC-daunorubicin-etoposide response modulators associated with outcomes in pediatric AML

Bibliographic Details
Title: Genome-wide CRISPR/Cas9 screen identifies AraC-daunorubicin-etoposide response modulators associated with outcomes in pediatric AML
Authors: Nguyen, Nam H. K. 1, Rafiee, Roya 1, Parcha, Phani K. 1, Tagmount, Abderrahmane 2, Rubnitz, Jeffrey 3, Ribeiro, Raul 3, Cao, Xueyuan 4, Pounds, Stanley B. 5, Vulpe, Christopher D. 2, Lamba, Jatinder K. 1, ∗
Source: In Blood Advances 11 March 2025 9(5):1078-1091
Database: ScienceDirect
More Details
ISSN:24739529
DOI:10.1182/bloodadvances.2024014157
Published in:Blood Advances
Language:English